Idorsia
Alice Matheron has extensive experience in market access and government affairs in the pharmaceutical industry. Alice is currently working as a Market Access Director at Idorsia Pharmaceuticals Ltd since February 2022. Prior to that, they held senior director and director roles at Blueprint Medicines from 2020 to 2022. Alice also served as the Director of Market Access & Affaires Publiques at CSL Behring from 2016 to 2020. Alice has worked as a Director of Market Access & Patient Insight at LEO Pharma France from 2013 to 2016 and as a Responsable Economie de la santé at Janssen Cilag from 2011 to 2013. Alice'scareer in market access started at Lundbeck, where they worked as a Responsable Accès au marché from 2007 to 2011.
Alice Matheron has attended both Université Paris Dauphine - PSL and Université Paris Cité, but no specific years or degrees in any field of study are provided.
This person is not in any offices
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.